DI LEO, Alfredo
 Distribuzione geografica
Continente #
NA - Nord America 19.218
AS - Asia 6.128
EU - Europa 4.264
SA - Sud America 1.574
AF - Africa 171
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 31.377
Nazione #
US - Stati Uniti d'America 19.032
SG - Singapore 2.703
CN - Cina 1.574
BR - Brasile 1.396
HK - Hong Kong 879
SE - Svezia 879
RU - Federazione Russa 865
DE - Germania 633
IT - Italia 440
VN - Vietnam 375
UA - Ucraina 345
GB - Regno Unito 314
FI - Finlandia 264
FR - Francia 119
IN - India 106
BE - Belgio 100
CA - Canada 96
ID - Indonesia 83
AR - Argentina 75
BD - Bangladesh 69
PL - Polonia 60
MX - Messico 47
IQ - Iraq 46
CI - Costa d'Avorio 44
ZA - Sudafrica 44
TR - Turchia 42
JP - Giappone 41
IE - Irlanda 38
ES - Italia 37
NL - Olanda 33
EC - Ecuador 29
AT - Austria 26
MA - Marocco 24
UZ - Uzbekistan 23
CZ - Repubblica Ceca 22
RO - Romania 22
PK - Pakistan 21
SA - Arabia Saudita 21
VE - Venezuela 19
IR - Iran 18
CO - Colombia 15
KE - Kenya 13
PH - Filippine 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
EG - Egitto 12
TN - Tunisia 12
AU - Australia 11
GT - Guatemala 11
IL - Israele 11
PE - Perù 10
CL - Cile 9
JO - Giordania 9
KR - Corea 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
LB - Libano 8
LT - Lituania 8
MY - Malesia 8
DZ - Algeria 7
EU - Europa 6
BB - Barbados 5
BG - Bulgaria 5
CR - Costa Rica 5
LV - Lettonia 5
MK - Macedonia 5
OM - Oman 5
QA - Qatar 5
BH - Bahrain 4
CH - Svizzera 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
MD - Moldavia 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LU - Lussemburgo 3
NP - Nepal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BW - Botswana 2
BY - Bielorussia 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GD - Grenada 2
GR - Grecia 2
HU - Ungheria 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
Totale 31.355
Città #
Fairfield 2.600
Woodbridge 1.918
Ashburn 1.807
Chandler 1.385
Singapore 1.340
Houston 1.280
Seattle 1.062
Cambridge 904
Hong Kong 875
Ann Arbor 863
Wilmington 820
Jacksonville 819
Nyköping 704
Dallas 587
Beijing 525
New York 328
Lawrence 292
Roxbury 286
Nanjing 254
Los Angeles 208
Bari 176
Des Moines 174
Dearborn 154
Inglewood 138
Boardman 127
Princeton 126
São Paulo 125
Brooklyn 112
Brussels 100
Munich 98
Ho Chi Minh City 96
Santa Clara 92
San Diego 89
Buffalo 82
Hanoi 79
Chicago 68
Nanchang 67
Shenyang 65
Jakarta 63
Moscow 59
Hebei 58
Dong Ket 55
Jiaxing 53
London 52
Warsaw 51
The Dalles 46
Abidjan 44
Helsinki 44
Changsha 42
Columbus 42
Rio de Janeiro 42
Tianjin 40
Dublin 39
Tokyo 39
Stockholm 38
Atlanta 37
Paris 37
Nuremberg 36
Frankfurt am Main 35
Belo Horizonte 33
Hefei 32
San Francisco 31
Johannesburg 29
Boston 27
Council Bluffs 27
Montreal 27
Pune 27
Brasília 26
Chennai 26
Denver 26
Porto Alegre 26
Redwood City 26
Falls Church 25
Guangzhou 25
Toronto 25
Curitiba 23
Orem 23
Zhengzhou 22
Augusta 21
Manchester 21
Shanghai 21
Dhaka 20
Brno 19
Kunming 19
Tashkent 19
Da Nang 18
Jinan 18
Mexico City 18
Milan 18
Mumbai 18
Haiphong 17
Hangzhou 16
Turku 16
Ankara 15
Ardabil 15
Baghdad 15
Norwalk 15
Phoenix 15
San Mateo 15
Vienna 15
Totale 22.667
Nome #
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 196
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 194
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 184
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 183
Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection 183
Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome? 183
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 179
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 178
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 174
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 172
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 169
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 169
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 169
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 167
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 164
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 162
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients 162
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 162
Anti-viral therapy in chronic HBV infection: a single centre experience. 161
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 161
Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation 160
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 154
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 153
Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial 152
Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions 152
Gut Microbiota Imbalance is Related to Sporadic Colorectal Neoplasms. A Pilot Study 152
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 151
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 150
Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident? 148
A mysterious case of gastroparesis: could the secret be found in a drink? 148
Serum fructosamine and colorectal adenomas 144
Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy. 142
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 141
Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1) 141
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 140
Estrogens, phytoestrogens and colorectal neoproliferative lesions 140
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 140
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 140
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients 139
Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma 139
Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. 138
Antagonistic activity of potential probiotic Lactobacilli against the ureolytic pathogen Yersinia enterocolitica 138
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 138
Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence 137
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 135
The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. 135
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 135
Lesson from an intriguing case of cryoglobulinemia 135
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 134
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 133
Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice 132
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 132
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy 131
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 131
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 131
H. pylori status and angiogenesis factors in human gastric carcinoma 129
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma 128
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 128
Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice 127
Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice 126
Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions 126
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 125
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 125
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 125
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. 124
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 124
Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics 123
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. 122
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 121
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 120
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 120
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 120
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 119
Sliding gastric hiatal hernia diagnosis by transabdominal ultrasonography: an easy, reliable and non-invasive procedure 117
Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage 116
Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a) 116
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 116
Evaluation of non-celiac gluten sensitivity in patients with previous diagnosis of irritable bowel syndrome: A randomized double-blind placebo-controlled crossover trial 116
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 115
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori 115
Improved efficacy of 10-Day sequential treatment for Helicobacter Pylori eradication in children: a randomized trial 114
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy. 112
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 112
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver. 111
In vitro gallbladder motility in patients with radiolucent and radiopaque stones. 110
Estrogens and colorectal cancer. 110
Sex steroid hormone receptors, epidermal growth factor receptor, and polyamines in human colorectal cancer. 110
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 110
Survival after the diagnosis of de novo malignancy in liver transplant recipients 110
Relationship among red blood cell polyamine content, phagocytic activities and plasma endotoxins in untreated colorectal cancer patients 109
Tumor necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 109
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 109
Estrogen receptor beta as target for colorectal cancer prevention 109
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 109
Sex steroid hormone receptors and human gallbladder motility in vitro. 108
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients 108
The association between cardiac and gastrointestinal disorders: causal or casual link? 108
Curcumin and colorectal cancer: From basic to clinical evidences 108
Helicobacter heilmannii infection of the antrum and duodenal bulb 107
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 106
Totale 13.645
Categoria #
all - tutte 138.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.222 0 0 0 0 0 191 385 412 243 484 257 250
2021/20222.125 127 187 55 99 110 178 82 132 142 157 350 506
2022/20233.490 491 429 243 287 383 491 35 402 553 21 95 60
2023/20241.218 104 229 52 113 91 350 29 39 8 57 15 131
2024/20255.367 125 78 407 135 154 477 638 544 266 300 782 1.461
2025/20266.197 1.752 569 1.054 1.173 1.439 210 0 0 0 0 0 0
Totale 32.427